The Medicare Interactive website just got an upgrade. Take a look today!
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of
Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Medicare Prescription Payment Plan (MPPP) draft guidance. Medicare Rights is a national, nonprofit organization that works to ensure access to affordable and equitable health care for older adults and people with disabilities through counseling and advocacy, educational programs, and public policy initiatives. Each year, Medicare Rights provides services and resources to over three million people with Medicare, family caregivers, and professionals.
Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of
Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10
In advance of the upcoming Medicare Fall Open Enrollment period, beginning October 15, the Biden-Harris administration announced that Medicare Advantage
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of
Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Medicare Prescription Payment Plan (MPPP) draft guidance. Medicare Rights is a national, nonprofit organization that works to ensure access to affordable and equitable health care for older adults and people with disabilities through counseling and advocacy, educational programs, and public policy initiatives. Each year, Medicare Rights provides services and resources to over three million people with Medicare, family caregivers, and professionals.
Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of
Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10
In advance of the upcoming Medicare Fall Open Enrollment period, beginning October 15, the Biden-Harris administration announced that Medicare Advantage
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
